The Menopause: Health Implications and Clinical Management
- 27 April 1993
- journal article
- review article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 41 (4) , 426-436
- https://doi.org/10.1111/j.1532-5415.1993.tb06953.x
Abstract
Objective: To review the anatomy, physiology, clinical symptoms, long‐term health effects, and treatment of the menopause and climacteric syndrome, with a special emphasis on features, such as incontinence, particularly relevant to geriatric medicine.Data sources: English‐language publications on menopause and the climacteric.Study selection: Articles and books containing recent information pertinent to the topics covered. Studies in human subjects were given priority, but primate studies that amplify physiologic concepts are included.Data synthesis: Due to increased longevity, the average US woman will spend one‐third of her life as a postmenopausal individual. Anatomic and physiologic changes associated with the peri‐ and postmenopausal state include hot flushes, genitourinary atrophy, and bone loss. Possible correlates of the menopausal transition and postmenopause include affective changes and unfavorable alterations in lipoproteins and other cardiac risk factors. Clinical correlates of these changes can include incontinence, sexual dysfunction, increased risk of fracture, dysphoric mood, and increased risk of cardiovascular disease. Formal indications for estrogen therapy are hot flushes, genital atrophy, and osteoporosis prevention; other common clinical uses are reviewed. Non‐contraceptive estrogens can be administered orally, transdermally, vaginally, or by injection. Each route and preparation has some unique features with respect to actions and side effects. Progestins, in adequate doses, protect against the unwanted side effect of endometrial hyperplasia; alternatives to progestin use are presented. Non‐hormonal alternatives for some peri‐ and postmenopausal symptoms are described.Conclusions: A discussion of the menopause and the benefits and risks of hormone therapy should be part of the routine health care of older women. Since the use of hormone therapy is elective, health care providers must elicit the goals, needs, and preferences of each patient, supply her with relevant information, and serve as a facilitator of her individual decision.Keywords
This publication has 112 references indexed in Scilit:
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- Postmenopausal Estrogen Replacement and Breast CancerNew England Journal of Medicine, 1989
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- A Simple Method for Determining the Optimal Dosage of Progestin in Postmenopausal Women Receiving EstrogensNew England Journal of Medicine, 1986
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- Effects of dydrogesterone on the oestrogenized postmenopausal endometriumBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- The Role of Estrogen in Migraine: A Review and HypothesisCephalalgia, 1984
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980
- Treatment of Stress Incontinence with Estrogen in Postmenopausal WomenUrologia Internationalis, 1977
- Postmenopausal Symptomatology, Maturation Index, and Plasma Estrogen LevelsObstetrics & Gynecology, 1975